Trial Profile
Prospective study investigating the changes on intraocular pressure after ranibizumab administration in patients with macular oedema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Pharmacodynamics
- 03 Dec 2015 New trial record